MD MPJE study materials
MD MPJE study resources

MD MPJE study plan

MD MPJE · Give each week a clear focus.

8 weeks · About 6 hours per week

Week 1

Maryland Pharmacy Practice Act: Board of Pharmacy structure, licensure, registration, and discipline & Licensure and registration of pharmacies, pharmacists, pharmacy technicians, and nonresident pharmacies

  • Map the Maryland Board of Pharmacy's composition, appointment process, officer roles, meeting cadence, and emergency/disciplinary authority from the Pharmacy Practice Act, writing a one-page structural outline.

  • Differentiate each license and registration type the Board issues (pharmacist, pharmacy, technician, nonresident pharmacy, and any device or outsourcing categories) by listing eligibility, renewal cycle, and continuing education attached to each.

  • Trace the Board's disciplinary pathway end to end, from complaint intake through investigation, consent order, hearing, and sanction, and note which violations trigger summary suspension.

  • Explain Maryland-specific licensure mechanics such as reciprocity/licensure by examination alternatives, intern and technician registration prerequisites, and the consequences of practicing on a lapsed license.

Your checkpoint

A two-page comparison table of every Maryland credential type with eligibility, renewal, CE, and discipline exposure columns, plus a 10-question self-quiz you answer at 80% or better.

Week 2

Prescription requirements, dispensing, labeling, and recordkeeping & Controlled substances: federal CSA scheduling, Maryland CDS law, prescription monitoring program, and CSOS/order requirements

  • Deconstruct a compliant Maryland prescription by labeling each required element (prescriber identifiers, drug, strength, quantity, directions, refills, date, and signature requirements) and identify when oral or electronic orders are permissible.

  • Build a side-by-side chart of federal CSA schedules I-V against Maryland's controlled dangerous substances schedules, flagging where Maryland is stricter or adds reporting duties.

  • Walk through the Maryland prescription monitoring program: who must query, when querying is mandatory versus discretionary, delegate access, and reporting timelines for dispensing.

  • Outline CSOS and DEA order form requirements, including who may sign, recordkeeping, and how Maryland rules layer on top of federal ordering rules.

Your checkpoint

A one-page annotated mock prescription with every legally required element labeled, plus a schedule comparison chart covering at least 15 drug examples placed in the correct federal and Maryland schedule.

Week 3

Prescription requirements, dispensing, labeling, and recordkeeping & Controlled substances: federal CSA scheduling, Maryland CDS law, prescription monitoring program, and CSOS/order requirements

  • Apply Maryland refill, transfer, and partial-fill rules to written scenarios, including controlled substance limits and emergency oral dispensing follow-up paperwork.

  • Specify recordkeeping obligations for prescriptions and controlled substances: retention periods, what must be readily retrievable, and how electronic records satisfy them.

  • Distinguish the federal DEA registration and recordkeeping duties from Maryland CDS permit, inventory, and theft/loss reporting duties, noting where both apply simultaneously.

  • Practice recognizing red flags and corresponding responsibility for controlled substance dispensing under both federal and Maryland standards.

Your checkpoint

A scenario workbook of 12 short cases (refills, transfers, partial fills, loss reporting, suspicious orders) with your written answer and cited rule for each, scoring at least 10 of 12 correct.

Week 4

Maryland Pharmacy Practice Act: Board of Pharmacy structure, licensure, registration, and discipline & Pharmacist duties, delegation, supervision, counseling, and collaborative practice agreements

  • Define the pharmacist's supervision and delegation boundaries, including which tasks may be delegated to technicians and interns and which require pharmacist judgment.

  • Explain Maryland counseling requirements: when counseling is required, permitted refusals, documentation expectations, and how counseling applies to new versus refill prescriptions.

  • Describe collaborative practice agreement requirements in Maryland, including eligible practitioners, patient criteria, documentation, and pharmacist authority to modify therapy.

  • Identify the pharmacist's corresponding responsibility and patient safety duties that persist regardless of delegation.

Your checkpoint

A delegation matrix listing at least 15 pharmacy tasks marked pharmacist-only, delegable-with-verification, or technician-permitted, plus a sample compliant collaborative practice agreement outline.

Week 5

Drug distribution systems: institutional pharmacy, automated devices, repackaging, compounding, and sterile products & Federal and Maryland law overlap: FDA, DEA, HIPAA, and drug recall/return handling

  • Compare Maryland requirements for inpatient institutional pharmacy services, including pharmacy and therapeutics functions, unit dose systems, and drug distribution controls.

  • Evaluate automated dispensing device rules: accountability, access control, override documentation, and reconciliation expectations in institutional and outpatient settings.

  • Outline compounding and sterile product standards, including the distinction between traditional and sterile compounding oversight and Maryland's adoption of USP standards.

  • Separate FDA, DEA, HIPAA, and Maryland roles in recall handling, returns, and reverse distribution, identifying which transactions require documentation or DEA Form 41.

Your checkpoint

A one-page decision flowchart for handling a drug recall and a separate flowchart for processing a returned controlled substance, each with the governing authority named at every branch.

Week 6

Federal and Maryland law overlap: FDA, DEA, HIPAA, and drug recall/return handling & Professional ethics, patient safety, medication errors, and quality improvement reporting

  • Map overlapping federal and Maryland authority on labeling, advertising, and prescription drug marketing so you can state which rule controls when they conflict.

  • Explain HIPAA privacy and security duties as they apply to pharmacy practice, including permitted disclosures to prescribers, law enforcement, and the prescription monitoring program.

  • Describe Maryland medication error reporting and quality improvement obligations, including what must be reported, to whom, and confidentiality protections.

  • Apply an ethical decision framework to scenarios involving impaired colleagues, dispensing errors, and patient privacy conflicts.

Your checkpoint

A two-page federal-versus-Maryland overlap sheet with at least 20 rows, plus written responses to 5 ethics and patient safety scenarios with the controlling rule cited for each.

Week 7

Maryland Pharmacy Practice Act: Board of Pharmacy structure, licensure, registration, and discipline & Licensure and registration of pharmacies, pharmacists, pharmacy technicians, and nonresident pharmacies & Prescription requirements, dispensing, labeling, and recordkeeping & Controlled substances: federal CSA scheduling, Maryland CDS law, prescription monitoring program, and CSOS/order requirements

  • Re-audit your weakest areas from weeks 1 to 3 by retaking your self-quizzes and logging every missed item with the specific rule you misapplied.

  • Answer timed mixed question sets drawn from licensure, dispensing, and controlled substances domains, targeting a pace of about one minute per question.

  • Rewrite your condensed rule sheets for the four heaviest domains into a single index you can scan in under 10 minutes.

  • Verify all numeric details (retention periods, renewal cycles, query timelines, refill limits) against your source materials and correct any note that lacks a citation.

Your checkpoint

A corrected, citation-backed one-page quick-reference sheet for domains 1 through 4, plus a log of at least 40 practice questions with error patterns categorized.

Week 8

Pharmacist duties, delegation, supervision, counseling, and collaborative practice agreements & Drug distribution systems: institutional pharmacy, automated devices, repackaging, compounding, and sterile products & Federal and Maryland law overlap: FDA, DEA, HIPAA, and drug recall/return handling & Professional ethics, patient safety, medication errors, and quality improvement reporting

  • Run two full-length timed practice exams under test conditions and score each by domain to confirm the heavy domains stay above your target.

  • Review every missed question from both exams and write a one-sentence rule statement for each miss.

  • Rehearse the delegation, collaborative practice, recall, and error reporting rules aloud until you can state them without notes.

  • Finalize a test-day plan covering timing strategy, how you will handle unfamiliar scenario stems, and your last-24-hour review list.

Your checkpoint

Two completed timed exams with domain score breakdowns, a final one-page master rule sheet covering all eight domains, and a written test-day strategy.

Milestones

Week 2: You can name every required prescription element and place 15 drugs into the correct federal and Maryland schedule without notes.

Week 4: You score at least 10 of 12 on your controlled substance scenario workbook and can explain the delegation boundaries for 15 pharmacy tasks.

Week 6: Your federal-versus-Maryland overlap sheet is complete and you can resolve 5 ethics scenarios citing the controlling authority for each.

Week 7: Your domain 1 through 4 quick-reference sheet is fully citation-backed and you are averaging at least 75% on timed mixed sets.

Week 8: Both full-length practice exams are complete with heavy domains (1, 3, 4) at or above 80% and a written test-day strategy in hand.